| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20006104 | HPV | ENSG00000148408.15 | protein_coding | CACNA1B | No | No | 774 | Q00975 |
| TVIS20023849 | HPV | ENSG00000148408.15 | protein_coding | CACNA1B | No | No | 774 | Q00975 |
| TVIS44026220 | HTLV-1 | ENSG00000148408.15 | protein_coding | CACNA1B | No | No | 774 | Q00975 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CACNA1B |
|---|---|
| DrugBank ID | DB01202 |
| Drug Name | Levetiracetam |
| Target ID | BE0002226 |
| UniProt ID | Q00975 |
| Regulation Type | inhibitor |
| PubMed IDs | 17461889; 11879381 |
| Citations | De Smedt T, Raedt R, Vonck K, Boon P: Levetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data. CNS Drug Rev. 2007 Spring;13(1):43-56.@@Lukyanetz EA, Shkryl VM, Kostyuk PG: Selective blockade of N-type calcium channels by levetiracetam. Epilepsia. 2002 Jan;43(1):9-18. |
| Groups | Approved |
| Direct Classification | Alpha amino acids and derivatives |
| SMILES | CC[C@H](N1CCCC1=O)C(N)=O |
| Pathways | |
| PharmGKB | PA450206 |
| ChEMBL | CHEMBL1286 |
